BioCentury
ARTICLE | Company News

FDA approves first 'artificial pancreas' for Type I diabetes

September 28, 2016 7:00 AM UTC

FDA approved the MiniMed 670G hybrid closed loop system from Medtronic plc (NYSE:MDT) to adjust insulin levels in Type I diabetics aged 14 and older with minimal input from the patient.

The system includes a sensor that measures glucose levels under the skin every five minutes, an insulin pump, and an infusion patch. It uses Medtronic's SmartGuard HCL algorithm to provide appropriate basal insulin doses based on a patient's glucose levels. Patients manually enter mealtime carbohydrates and request insulin doses to counter meal consumption. ...